Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | A phase 2, multi-center, open-label study of cinrebafusp alfa (PRS-343) in patients with HER2-high and HER2-low gastric or gastroesophageal junction (GEJ) adenocarcinoma | ANNALS OF ONCOLOGY |